Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-04-01
2009-11-24
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S113000
Reexamination Certificate
active
07622480
ABSTRACT:
This invention is directed to selective antagonists of H1histamine receptors having the general formula (I); to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.
REFERENCES:
patent: WO 98/20875 (1998-05-01), None
patent: WO 00 75130 (2000-12-01), None
patent: WO 02 14317 (2002-02-01), None
patent: WO 02 20013 (2002-03-01), None
patent: WO 02 36589 (2002-05-01), None
patent: WO02/051837 (2002-07-01), None
patent: WO02/079151 (2002-10-01), None
Cardus Figueras Aranzazu
Fonquerna Pou Silvia
Pages Santacana Luis Miguel
Prieto Soto José Manuel
Puig Duran Carlos
Dentz Bernard
Finnegan Henderson Farabow Garrett & Dunner LLP
Gallis David E
Laboratorios Almirall S.A.
LandOfFree
Azaindolylpiperidine derivatives as antihistaminic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaindolylpiperidine derivatives as antihistaminic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaindolylpiperidine derivatives as antihistaminic and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4118105